Education
About Us
Working with TipRanks
Follow Us
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
4577 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥970.00 - ¥1,311.00
Previous CloseN/A
Volume21.10K
Average Volume (3M)49.43K
Market Cap
¥35.93B
Enterprise Value¥46.59B
Total Cash (Recent Filing)¥2.38B
Total Debt (Recent Filing)¥10.49B
Price to Earnings (P/E)19.0
Beta0.29
Next Earnings
Jan 09, 2026EPS EstimateN/A
Next Dividend Ex-Date
Nov 27, 2025Dividend Yield4.41%
Share Statistics
EPS (TTM)23.24
Shares Outstanding30,096,880
10 Day Avg. Volume50,900
30 Day Avg. Volume49,426
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,261.00Price Target Upside5.88% Upside
Rating ConsensusHold
Number of Analyst Covering0
Daito Pharmaceutical Co., Ltd. News
4577 FAQ
What was Daito Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Daito Pharmaceutical Co., Ltd. lowest stock price was ¥970.00 and its highest was ¥1311.00 in the past 12 months.
What is Daito Pharmaceutical Co., Ltd.’s market cap?
Daito Pharmaceutical Co., Ltd.’s market cap is ¥35.93B.
When is Daito Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Daito Pharmaceutical Co., Ltd.’s upcoming earnings report date is Jan 09, 2026 which is in 90 days.
How were Daito Pharmaceutical Co., Ltd.’s earnings last quarter?
Daito Pharmaceutical Co., Ltd. released its earnings results on Oct 10, 2025. The company reported ¥23.24 earnings per share for the quarter, beating the consensus estimate of N/A by ¥23.24.
Is Daito Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Daito Pharmaceutical Co., Ltd.’s price is currently Undervalued.
Does Daito Pharmaceutical Co., Ltd. pay dividends?
Daito Pharmaceutical Co., Ltd. pays a Semiannually dividend of ¥20 which represents an annual dividend yield of 4.41%. See more information on Daito Pharmaceutical Co., Ltd. dividends here
What is Daito Pharmaceutical Co., Ltd.’s EPS estimate?
Daito Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daito Pharmaceutical Co., Ltd. have?
Daito Pharmaceutical Co., Ltd. has 30,096,880 shares outstanding.
What happened to Daito Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Daito Pharmaceutical Co., Ltd. reported an EPS of ¥23.24 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.588%.
Which hedge fund is a major shareholder of Daito Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4577
Company Description
Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. (4577) is a Japan-based company specializing in the development, manufacturing, and marketing of pharmaceutical products. The company operates primarily in the sectors of prescription drugs, over-the-counter medications, and biopharmaceuticals. Daito Pharmaceutical focuses on therapeutic areas such as oncology, cardiology, and infectious diseases, offering a range of innovative medications and healthcare solutions to improve patient outcomes.
Technical Analysis
Fuji Pharma Co., Ltd.
―
Pharma Foods International Co., Ltd.
―
Fuso Pharmaceutical Industries,Ltd.
―
Taiko Pharmaceutical Co., Ltd.
―
Mizuho Medy Co., Ltd.
―
Options Prices
Currently, No data available
---